Pfizer announces the election of Cyrus Taraporevala to its Board of Directors, effective immediately. Cyrus Taraporevala, 57, has also been appointed to the Pfizer Board's Audit Committee and Compensation Committee.

Pfizer notes that Mr. Taraporevala was an officer of State Street Global Advisors from 2017 until his retirement in 2022. Prior to joining State Street, he held a number of senior positions in asset management, including at Fidelity, BNY Mellon, Legg Mason and Citigroup.

He also sits on the boards of Shell plc and Bridgepoint Group plc.

Copyright (c) 2024 CercleFinance.com. All rights reserved.